Day: May 6, 2024

2023 Revenue of $4.9m in 2023 Technological innovations elevate product offering including AI Virtual Concierge and SAAS based platform Growth of global Channel Partners expected to scale revenue in 2024 and beyond Q1 2024 revenue of approximately $1.6mTORONTO, May 06, 2024 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV: ART), (OTCQB: ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, today announced its financial operating results for the fiscal year ended December 31, 2023 which are available on SEDAR. “While our financial results were disappointing in 2023, our technological innovations were the best in the history of ARHT which in turn has created a reliable, patent-protected, superior product,”...

Supply chain in place and vehicle submitted for road and safety certification GRAND CAYMAN, Cayman Islands and COIMBATORE, India, May 06, 2024 (GLOBE NEWSWIRE) — SRIVARU Holding Limited (Nasdaq: SVMH; SVMHW) (“SRIVARU” or the “Company”), a prominent provider of premium electric motorcycles, today announced that it has successfully completed the internal testing of its PRANA 2.0 electric motorcycle, resulting in a full production model being submitted for final certification by applicable road and safety authorities. Additionally, the Company reports that its complete supply network is in place for production of the PRANA 2.0 upon final certification. Mohanraj Ramasamy, CEO of SRIVARU, commented, “Completion of the production version of PRANA 2.0 marks a major milestone for SRIVARU. Following successful internal testing, we have...

SYDNEY, Australia, May 06, 2024 (GLOBE NEWSWIRE) — IREN (Iris Energy Limited) (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), a leading next-generation data center business powering the future of Bitcoin, AI and beyond, today announced that it will release its financial results for the three-months ended March 31, 2024, on Wednesday, May 15, 2024 USA Eastern Daylight Time and will host a conference call beginning at 5:00 p.m. USA Eastern Daylight Time. The webcast will be recorded, and the replay will be accessible shortly after the event at https://iren.com/investor/events-and-presentationsWebcast and Conference Call DetailsTime & Date: 5:00 p.m. USA Eastern Daylight Time, Wednesday, May 15, 2024  7:00 a.m. Australian Eastern Standard Time, Thursday, May 16, 2024  Participant Registration...

SYDNEY, Australia, May 06, 2024 (GLOBE NEWSWIRE) — IREN (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), a leading next-generation data center business powering the future of Bitcoin, AI and beyond, today published a monthly investor update for April 2024. Key HighlightsBitcoin Mining AI Cloud Services358 Bitcoin mined in April 9.4 EH/s operating, 10 EH/s in May Expansion ahead of schedule816 NVIDIA H100 GPUs Upsized and extended agreement with PoolsideData Centers Corporate245MW operating, 510MW in 2024 Childress Phase 3 expansion upsized by 50MW, supporting growth beyond 20 EH/s in 20243Q FY24 results release on May 15, 2024, register here 20 EH/s expansion fully fundedKey MetricsBitcoin Mining1 Apr-24 Mar-24 Feb-24Average operating hashrate (PH/s) 8,238 7,107 6,299Renewable...

DURHAM, N.C., May 06, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced an updated issuance date for the company’s first quarter 2024 financial results. The Company requires additional time to work through accounting and discontinued operations matters primarily as a result of entering into a definitive agreement in March 2024 to divest assets relating to the Company’s Enabling Services segment. Fortrea will now release its first quarter 2024 financial results before the market opens on Monday, May 13, 2024, rather than on Tuesday, May 7, 2024, as previously announced. The company will host a conference call at 8:00 am ET on the date of release to review its financial results and conduct a question-and-answer session. To participate in the earnings...

– Stockholders’ equity significantly surpasses the $2.5 million minimum required by Nasdaq – Company is to seek Nasdaq’s formal confirmation of compliance with equity requirements under the exchange’s Rule 5550(b)(1). – Company will submit a request to the SEC to withdraw Form S-1 Boston (May 6, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that its stockholders’ equity is significantly above the $2.5 million minimum required by Nasdaq Listing Rule 5550(b)(1)(the “Equity Rule”). The Company is in the process of obtaining official written confirmation from Nasdaq, which will reinstate its full compliance with Nasdaq listing requirements. In line with this progress, Allarity plans...

Lassila & Tikanoja plcStock exchange release6 May 2024 at 3.00 p.m. Joni Sorsanen appointed CFO of Lassila & Tikanoja plc Joni Sorsanen (M.Sc. Econ) has been appointed as Chief Financial Officer of Lassila & Tikanoja and a member of the Group Executive Board effective latest 10 July 2024. Sorsanen joins L&T from Consti plc where he serves as Chief Financial Officer. “I’m pleased to welcome Joni to our Group Executive Board to develop and lead business-driven financial operations in the Group” says Eero Hautaniemi, President and CEO of Lassila & Tikanoja. Sorsanen has extensive experience in leading and developing finance departments in listed companies. He reports to L&T’s CEO, Eero Hautaniemi. Sorsanen’s photo and résumé are available at the company website: https://www.lt.fi/en/company/group-executive-board LASSILA...

SAN FRANCISCO and WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, COPD, asthma and other inflammatory and immunology indications, today announced that Michael Henderson, M.D., Chief Executive Officer and Jane Pritchett Henderson, Chief Financial Officer, will participate in a fireside chat at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024 at 3:40 p.m. P.T. / 6:40 p.m. E.T. A live and archived webcast of the fireside chat will be available via the News & Events page in the Investors section of the Apogee Therapeutics website. About Apogee Therapeutics Apogee Therapeutics is a clinical-stage biotechnology company seeking to develop differentiated...

CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its first quarter 2024 financial results will be released on Monday, May 13, 2024 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments. Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website...